The Rajasthan Health Department has clarified that the recent deaths of two children in Bharatpur and Sikar districts were not caused by cough syrup distributed under the state's free medicine scheme, according to an official statement.
Public Health Director Ravi Prakash Sharma said inquiry reports confirmed that in both cases, the children were administered the syrup at home without a doctor's advice.
As per protocol, Dextromethorphan (DXM) drug is not prescribed to children, Sharma said in the statement released on Thursday and added that in both incidents, the doctors had not prescribed the drug.
Health Minister Gajendra Singh had earlier ordered a probe into the matter after reports of poor-quality cough syrup surfaced.
Following the order, the Rajasthan Medical Services Corporation Limited (RMSCL) halted the supply and use of the drug, formed a three-member inquiry committee and sent some samples for testing at the state drug laboratory.
However, in another case from Sikar, a child was wrongly prescribed a cough syrup containing the drug DXM. Subsequently, the Health Department initiated suspension proceedings against the doctor and pharmacist concerned for violating protocol.
The department has also issued an advisory directing doctors to strictly follow prescription protocols and ensure medicines are dispensed only against prescriptions. It also urged the public not to take medicines without medical advice.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)